Albemarle (ALB) Stock Sinks As Market Gains: What You Should Know
📉 Albemarle (ALB) stock fell 2.84% to $173.03, lagging the S&P 500's 0.44% gain.
🧬 The basic materials sector lost 5.22% over the month while ALB rose 9.74%.
📅 Investors await upcoming earnings with expected EPS of $0.78 and revenue of $1.28 billion.
📈 Analyst estimates forecast full-year earnings growth of 1,131.65% to $8.15 per share.
🧠 Positive analyst estimate revisions often signal future stock price performance.
🔢 Albemarle currently holds a Zacks Rank of #3 (Hold) with recent EPS estimate increases of 3.51%.
⚖️ The company's Forward P/E ratio of 21.85 is higher than the industry average of 18.86.
📊 ALB's PEG ratio of 1.37 reflects expected earnings growth relative to valuation multiples.
🏭 The Chemical - Diversified industry ranks in the bottom 7% across over 250 sectors.
🏆 Zacks Industry Rank #227 indicates average industry outperformance by top-rated groups.
Bullish Signals
- Shares of Albemarle (ALB) gained 9.74% over the previous month, significantly outperforming both the Basic Materials sector's loss of 5.22% and the S&P 500's decline of 3.31%.
- Consensus estimates predict a massive 533.33% increase in quarterly earnings per share (EPS) to $0.78, with revenue expected to rise 18.91% to $1.28 billion for the quarter.
- For the entire fiscal year, analysts project earnings of $8.15 per share and revenue of $5.58 billion, representing a staggering 1131.65% increase in EPS compared to the prior year.
- Zacks Consensus EPS estimates have moved 3.51% higher over the last 30 days, reflecting growing optimism about the stock's future performance.
- Albemarle holds a Zacks Rank of #3 (Hold), which is considered a positive rating system with a proven track record of superior performance for investors.
Risk Factors
- Albemarle stock closed at $173.03, declining by -2.84% on the most recent trading day while the broader market advanced.
- The stock underperformed significantly compared to the S&P 500, which gained 0.44%, indicating investor caution relative to the overall market.
- Albemarle currently carries a premium Forward P/E ratio of 21.85 compared to its industry average of 18.86, suggesting higher valuation risks.
- The company's PEG ratio of 1.37 is below the Chemical - Diversified industry average of 1.63, though still indicates growth expectations may not be fully priced in relative to peers.
- Albemarle holds a Zacks Rank of #3 (Hold), positioning it in the bottom 7% of all industries based on the Zacks Industry Rank assessment.
- Research indicates that top-rated industries outperform the bottom half by a factor of 2 to 1, raising concerns about ALB's relative performance potential given its ranking.
Full Analysis
Albemarle (ALB) stock closed at $173.03 on the most recent trading day, marking a decline of 2.84% and lagging behind major market indices as the S&P 500 gained 0.44%, the Dow rose 0.36%, and the Nasdaq increased by 0.54%. Despite this recent dip, ALB shares have posted a 9.74% gain over the previous month, outperforming both the Basic Materials sector, which fell 5.22%, and the S&P 500, which dropped 3.31%. Investors are expected to focus on Albemarle's upcoming earnings report, with consensus estimates predicting quarterly earnings per share (EPS) of $0.78, representing a significant 533.33% increase from the prior-year quarter, and revenue of $1.28 billion, up 18.91% year-over-year.
On a fiscal year basis, Zacks Consensus Estimates project earnings of $8.15 per share and revenue of $5.58 billion, with projected changes of +1131.65% and +8.48% respectively from the previous year. Analyst estimate revisions are highlighted as a key indicator for short-term stock performance, with research indicating that positive adjustments correlate with near-future price movements. Currently, Albemarle holds a Zacks Rank of #3 (Hold), and over the last 30 days, the consensus EPS estimate has risen by 3.51%.
In terms of valuation metrics, ALB trades at a Forward P/E ratio of 21.85, which is above the industry average of 18.86. The company's PEG ratio stands at 1.37 compared to an industry average of 1.63, reflecting its expected earnings growth rate against price. Additionally, Albemarle operates within the Chemical - Diversified industry, which has a Zacks Industry Rank of 227, placing it in the bottom 7% of over 250 industries tracked. The analysis notes that top 50% rated industries historically outperform the bottom half by a factor of 2 to 1, suggesting potential performance implications based on industry strength ratings.
